ArticleMolecular medicine reports2017

Synergistic antitumor effects of CDK inhibitor SNS‑032 and an oncolytic adenovirus co‑expressing TRAIL and Smac in pancreatic cancer.

Yun Ge et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.